Literature DB >> 32313261

Sequence variant analysis reveals poor correlations in microbial taxonomic abundance between humans and mice after gnotobiotic transfer.

Farnaz Fouladi1, Elaine M Glenny2, Emily C Bulik-Sullivan2, Matthew C B Tsilimigras1,2, Michael Sioda1, Stephanie A Thomas2, Yunfei Wang3, Zorka Djukic2, Quyen Tang2, Lisa M Tarantino4,5, Cynthia M Bulik2,6,7, Anthony A Fodor8, Ian M Carroll9,10.   

Abstract

Transplanting human gut microbiotas into germ-free (GF) mice is a popular approach to disentangle cause-and-effect relationships between enteric microbes and disease. Algorithm development has enabled sequence variant (SV) identification from 16S rRNA gene sequence data. SV analyses can identify which donor taxa colonize recipient GF mice, and how SV abundance in humans is replicated in these mice. Fecal microbiotas from 8 human subjects were used to generate 77 slurries, which were transplanted into 153 GF mice. Strong correlations between fecal and slurry microbial communities were observed; however, only 42.15 ± 9.95% of SVs successfully transferred from the donor to the corresponding recipient mouse. Firmicutes had a particularly low transfer rate and SV abundance was poorly correlated between donor and recipient pairs. Our study confirms human fecal microbiotas colonize formerly GF mice, but the engrafted community only partially resembles the input human communities. Our findings emphasize the importance of reporting a standardized transfer rate and merit the exploration of other animal models or in silico tools to understand the relationships between human gut microbiotas and disease.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32313261      PMCID: PMC7305193          DOI: 10.1038/s41396-020-0645-z

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  1 in total

1.  Deblur Rapidly Resolves Single-Nucleotide Community Sequence Patterns.

Authors:  Amnon Amir; Daniel McDonald; Jose A Navas-Molina; Evguenia Kopylova; James T Morton; Zhenjiang Zech Xu; Eric P Kightley; Luke R Thompson; Embriette R Hyde; Antonio Gonzalez; Rob Knight
Journal:  mSystems       Date:  2017-03-07       Impact factor: 6.496

  1 in total
  10 in total

1.  Association of Increased Serum Lipopolysaccharide, But Not Microbial Dysbiosis, With Obesity-Related Osteoarthritis.

Authors:  Richard F Loeser; Liubov Arbeeva; Kathryn Kelley; Anthony A Fodor; Shan Sun; Veronica Ulici; Lara Longobardi; Yang Cui; Delisha A Stewart; Susan J Sumner; M Andrea Azcarate-Peril; R Balfour Sartor; Ian M Carroll; Jordan B Renner; Joanne M Jordan; Amanda E Nelson
Journal:  Arthritis Rheumatol       Date:  2022-01-04       Impact factor: 10.995

2.  Caloric restriction disrupts the microbiota and colonization resistance.

Authors:  Reiner Jumpertz von Schwartzenberg; Jordan E Bisanz; Svetlana Lyalina; Peter Spanogiannopoulos; Qi Yan Ang; Jingwei Cai; Sophia Dickmann; Marie Friedrich; Su-Yang Liu; Stephanie L Collins; Danielle Ingebrigtsen; Steve Miller; Jessie A Turnbaugh; Andrew D Patterson; Katherine S Pollard; Knut Mai; Joachim Spranger; Peter J Turnbaugh
Journal:  Nature       Date:  2021-06-23       Impact factor: 69.504

3.  Gut microbial communities from patients with anorexia nervosa do not influence body weight in recipient germ-free mice.

Authors:  Elaine M Glenny; Farnaz Fouladi; Stephanie A Thomas; Emily C Bulik-Sullivan; Quyen Tang; Zorka Djukic; Yesel S Trillo-Ordonez; Anthony A Fodor; Lisa M Tarantino; Cynthia M Bulik; Ian M Carroll
Journal:  Gut Microbes       Date:  2021 Jan-Dec

4.  Effects of caloric restriction on the gut microbiome are linked with immune senescence.

Authors:  Julia Sbierski-Kind; Sophia Grenkowitz; Stephan Schlickeiser; Hans-Dieter Volk; Joachim Spranger; Reiner Jumpertz von Schwartzenberg; Arvid Sandforth; Marie Friedrich; Désirée Kunkel; Rainer Glauben; Sebastian Brachs; Knut Mai; Andrea Thürmer; Aleksandar Radonić; Oliver Drechsel; Peter J Turnbaugh; Jordan E Bisanz
Journal:  Microbiome       Date:  2022-04-04       Impact factor: 16.837

5.  Human Fecal Microbiota Transplantation Reduces the Susceptibility to Dextran Sulfate Sodium-Induced Germ-Free Mouse Colitis.

Authors:  Yapeng Yang; Xiaojiao Zheng; Yuqing Wang; Xiang Tan; Huicong Zou; Shuaifei Feng; Hang Zhang; Zeyue Zhang; Jinhui He; Bota Cui; Xueying Zhang; Zhifeng Wu; Miaomiao Dong; Wei Cheng; Shiyu Tao; Hong Wei
Journal:  Front Immunol       Date:  2022-02-14       Impact factor: 7.561

6.  Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis.

Authors:  Anshul Sinha; Yue Li; Mohammadali Khan Mirzaei; Michael Shamash; Rana Samadfam; Irah L King; Corinne F Maurice
Journal:  Microbiome       Date:  2022-07-08       Impact factor: 16.837

7.  Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.

Authors:  Na Li; Bin Zuo; Shimeng Huang; Benhua Zeng; Dandan Han; Tiantian Li; Ting Liu; Zhenhua Wu; Hong Wei; Jiangchao Zhao; Junjun Wang
Journal:  Microbiome       Date:  2020-11-18       Impact factor: 14.650

8.  The Initial Gut Microbiota and Response to Antibiotic Perturbation Influence Clostridioides difficile Clearance in Mice.

Authors:  Sarah Tomkovich; Joshua M A Stough; Lucas Bishop; Patrick D Schloss
Journal:  mSphere       Date:  2020-10-21       Impact factor: 4.389

9.  Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients.

Authors:  Yueqiong Ni; Zoltan Lohinai; Yoshitaro Heshiki; Balazs Dome; Judit Moldvay; Edit Dulka; Gabriella Galffy; Judit Berta; Glen J Weiss; Morten O A Sommer; Gianni Panagiotou
Journal:  ISME J       Date:  2021-05-17       Impact factor: 10.302

10.  Geographic differences in gut microbiota composition impact susceptibility to enteric infection.

Authors:  Ana Maria Porras; Qiaojuan Shi; Hao Zhou; Rowan Callahan; Gabriella Montenegro-Bethancourt; Noel Solomons; Ilana Lauren Brito
Journal:  Cell Rep       Date:  2021-07-27       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.